Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
| Revenue (TTM) | $279.99M |
| Gross Profit (TTM) | $99.72M |
| EBITDA | $5.43M |
| Operating Margin | -5.38% |
| Return on Equity | 4.64% |
| Return on Assets | -1.48% |
| Revenue/Share (TTM) | $2.10 |
| Book Value | $2.00 |
| Price-to-Book | 0.74 |
| Price-to-Sales (TTM) | 0.70 |
| EV/Revenue | 0.97 |
| EV/EBITDA | 35.49 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 48.70% |
| Shares Outstanding | $140.64M |
| Float | $94.26M |
| % Insiders | 31.22% |
| % Institutions | 8.96% |
Volatility is currently expanding